Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways
Article in Cancer Cell International (March 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer
Article in Drug Resistance Updates (January 2024)
PET receptor imaging in breast cancer
Article in Clinical and Translational Imaging (October 2023)